SEC 13F Intelligence

Bokf, Na / ABBV

Bokf, Na’s Abbvie Inc Position

Does Bokf, Na own Abbvie Inc (ABBV)? Yes201.2K shares worth $44M (+0.67% of its 13F portfolio) as of Q1 2026, down from 220.7K shares the prior filed quarter.

Position Value
$44M
Q1 2026
Shares
201.2K
% of Portfolio
+0.67%
Quarters Held
28
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $20MQ4 ’18Q1 ’19: $11MQ2 ’19: $11MQ3 ’19: $12MQ4 ’19: $14MQ4 ’19Q1 ’20: $16MQ2 ’20: $27MQ3 ’20: $27MQ4 ’20: $120MQ4 ’20Q1 ’21: $123MQ3 ’21: $73MQ1 ’22: $67MQ2 ’22: $63MQ2 ’22Q3 ’22: $51MQ4 ’22: $60MQ1 ’23: $53MQ2 ’23: $42MQ2 ’23Q3 ’23: $43MQ4 ’23: $49MQ1 ’24: $47MQ2 ’24: $45MQ2 ’24Q3 ’24: $52MQ4 ’24: $47MQ1 ’25: $52MQ2 ’25: $46MQ2 ’25Q3 ’25: $55MQ4 ’25: $50MQ1 ’26: $44Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026201.2K$44M+0.67%
Q4 2025220.7K$50M+0.77%
Q3 2025237.0K$55M+0.83%
Q2 2025245.4K$46M+0.74%
Q1 2025250.2K$52M+0.93%
Q4 2024268.5K$47M+0.79%
Q3 2024268.6K$52M+0.93%
Q2 2024264.9K$45M+0.82%
Q1 2024259.9K$47M+0.86%
Q4 2023319.3K$49M+0.97%
Q3 2023303.7K$43M+0.95%
Q2 2023315.0K$42M+0.86%
Q1 2023331.1K$53M+1.10%
Q4 2022374.0K$60M+1.12%
Q3 2022380.3K$51M+1.03%
Q2 2022409.3K$63M+1.20%
Q1 2022413.5K$67M+1.10%
Q3 2021678.7K$73M+1.26%
Q1 20211.14M$123M+2.24%
Q4 20201.12M$120M+2.29%
Q3 2020311.4K$27M+0.60%
Q2 2020270.9K$27M+0.63%
Q1 2020211.1K$16M+0.46%
Q4 2019161.9K$14M+0.32%
Q3 2019161.7K$12M+0.29%
Q2 2019145.4K$11M+0.25%
Q1 2019132.0K$11M+0.25%
Q4 2018215.5K$20M+0.57%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bokf, Na’s full portfolio or all institutional holders of ABBV.